Nothing Special   »   [go: up one dir, main page]

HK1257591A1 - Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine - Google Patents

Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine

Info

Publication number
HK1257591A1
HK1257591A1 HK18116710.5A HK18116710A HK1257591A1 HK 1257591 A1 HK1257591 A1 HK 1257591A1 HK 18116710 A HK18116710 A HK 18116710A HK 1257591 A1 HK1257591 A1 HK 1257591A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
tissue damage
kidney tissue
treating pathologic
Prior art date
Application number
HK18116710.5A
Other languages
Chinese (zh)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257591A1 publication Critical patent/HK1257591A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116710.5A 2016-12-15 2018-12-28 Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine HK1257591A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15
CN201611162257 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257591A1 true HK1257591A1 (en) 2019-10-25

Family

ID=62658161

Family Applications (3)

Application Number Title Priority Date Filing Date
HK18116710.5A HK1257591A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine
HK18116705.2A HK1257586A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating kidney fibrosis and use of the medicine
HK18116709.8A HK1257590A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating medicinal kidney injury and the use of the medicine

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK18116705.2A HK1257586A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating kidney fibrosis and use of the medicine
HK18116709.8A HK1257590A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating medicinal kidney injury and the use of the medicine

Country Status (2)

Country Link
CN (3) CN108210908A (en)
HK (3) HK1257591A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201902419D0 (en) * 2019-02-22 2019-04-10 Singapore Health Serv Pte Ltd Treatment of kidney injury
JP2023514819A (en) * 2020-02-26 2023-04-11 タレンゲン インターナショナル リミテッド Methods and drugs for preventing and treating hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013510321A (en) * 2009-11-07 2013-03-21 アスチュート メディカル，インコーポレイテッド Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
HK1257590A1 (en) 2019-10-25
HK1257586A1 (en) 2019-10-25
CN108210894A (en) 2018-06-29
CN108210893A (en) 2018-06-29
CN108210908A (en) 2018-06-29

Similar Documents

Publication Publication Date Title
IL272948A (en) Enpp1 inhibitors and their use for the treatment of cancer
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
EP3551100A4 (en) Medical devices for treating hard tissues and related methods
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
LT3227237T (en) Device and use thereof for the uv treatment of fluids
HK1257239A1 (en) Medicine for preventing and treating obesity and use of the medicine
HK1257589A1 (en) Medicine for preventing and treating tissue and organ fibrosis and use of the medicine
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
IL271878A (en) Use of wx-uk1 and its prodrug, wx-671, for the treatment of non-cancerous medical conditions
IL265824A (en) Methods and pharmaceutical compositions for the treatment of kidney cancer
EP3723742C0 (en) Use of fluoroethylnormemantine for the prevention and treatment of anxiety
HK1257591A1 (en) Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine
HK1257238A1 (en) Medicine for preventing and treating lipid kidney injury and use of the medicine
IL269121A (en) Usl-311 for use in the treatment of cancer
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
IL251407A0 (en) Multivalent compounds for use in the treatment and prevention of brain damage
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL273863A (en) Device for use in the treatment of hemorrhoids
EP3648789C0 (en) Mtmr2-s polypeptide for use in the treatment of myopathies
EP3490604C0 (en) Medicament for the treatment and/or prevention of endometriosis